Skip Nav Destination
You do not currently have access to this content.
DAP5, ICAM1, and CTBP1 Inhibit the Fitness of CD8+ Effector T Cells Available to Purchase
March 28, 2024
Major Finding: Dap5, Icam1, and Ctbp1 were demonstrated to contribute to traits that limit T-cell antitumor activity.
Concept: CRISPR–Cas9 knockout screens were used to identify genes that contribute to T-cell fitness upon differential stimulation.
Impact: This study highlights regulators of T-cell fitness that could be targeted to enhance immunotherapy.
DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-050
Article Type:
Research Watch
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Advertisement